MANAGEMENT RECOMMENDATIONS

Antigen avoidance is effective for HP, but is typically insufficient in isolation in fibrotic HP.1

Lung transplantation should be recommended in patients with progressive, end-stage HP.5

Steroid-sparing immunosuppressants are the cornerstone of treatment because HP is inflammation driven.1 The effectiveness of available immunosuppressive regimens needs to be validated with prospective randomized trials.1

See also

Patient Case Study 1

Test your knowledge

Take the test

bridging gaps in ILD education image

Bridging Educational Gaps in ILD

Learn more

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media